Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07283653
Status
Recruiting
Apply to this trial

Conditions

  • DIGEST
  • Dysphagia
  • Evidence Based Measurement
  • Randomized Implementation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    receive no active implementation
  • DIGEST Training Program — OTHER
    Investigator led training program
  • DIGEST Training + Practice Facilitation — OTHER
    Training plus practice facilitation

Study Details

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Key Dates

Start date
Jun 1, 2025
Status verified
Feb 2026
Primary completion
Aug 1, 2027
Completion
Jan 31, 2029

Study Design

Enrollment
85 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Control Arm 1
    The control arm will receive no active implementation strategy.
  • Experimental: Training Arm 2
    Represents a low intensity implementation strategy solely using the DIGEST training program as the intervention.
  • Experimental: Training + Practice Facilitation Arm 3
    Represents a higher intensity strategy using the same training program plus practice facilitation.

Primary Outcome Measure

Adoption of DIGEST in routine clinical documentation for oncology MBS studies [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Kate Hutcheson, PHD
[email protected]
713-792-6513
Kate Hutcheson, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies